Company intelligence
American Society of Gene & Cell Therapy
ASGCT is the primary membership organization for professionals working in gene and cell therapy.
About American Society of Gene & Cell Therapy
The American Society of Gene & Cell Therapy is the primary professional membership organization for gene and cell therapy. The Society's members are scientists, physicians, patient advocates, and other professionals. Our members work in a wide range of settings including universities, hospitals, government agencies, foundations, and biotechnology and pharmaceutical companies. The mission of ASGCT is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. ASGCT's strategic vision is to be a catalyst for bringing together scientists, physicians, patient advocates, and other stakeholders to transform the practice of medicine by incorporating the use of genetic and cellular therapies to control and cure human disease.
Verified activity
Signals from American Society of Gene & Cell Therapy
8 published signals
Research & Knowledge
American Society of Gene & Cell Therapy published the September edition of the ASGCT Insider, featuring recent industry news, a Q&A with ASGCT member Max G. Bronstein, and more.
Reported by American Society of Gene & Cell Therapy
Presence & Recognition
American Society of Gene & Cell Therapy is attending the 2026 Policy Summit, which is less than one week away.
Reported by American Society of Gene & Cell Therapy
Presence & Recognition
American Society of Gene & Cell Therapy CEO David Barrett contributed his thoughts on the momentum occurring across the field to BioWorld News
Reported by American Society of Gene & Cell Therapy
Presence & Recognition
American Society of Gene & Cell Therapy honored Rami Major, Ph.D., as its 2025-2026 Congressional Policy Fellow.
Reported by American Society of Gene & Cell Therapy
Presence & Recognition
American Society of Gene & Cell Therapy is hosting a workshop titled Rethinking Clinical Delivery, Regulation, and Payment Models for Individualized Platform-Based Genome Editing Therapies on Tuesday, September 29 from 9 AM to 5 PM ET.
Reported by American Society of Gene & Cell Therapy
Research & Knowledge
American Society of Gene & Cell Therapy published the September 2026 issue of Molecular Therapy online.
Reported by American Society of Gene & Cell Therapy
Research & Knowledge
American Society of Gene & Cell Therapy is urging the HHS Office of Information Governance to establish clearer protections for clinical trial participant support, including a safe harbor for reasonable participation-related costs.
Reported by American Society of Gene & Cell Therapy
Presence & Recognition
American Society of Gene & Cell Therapy is hosting its next Molecular Therapy Presents webinar on October 21 to discuss scientific innovations and challenges in gene therapy, cell therapy, genome editing, and precision medicine for rare and ultra-rare diseases.
Reported by American Society of Gene & Cell Therapy